Rallybio CorporationRLYBNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-21.6%
5Y CAGR+2.1%
Year-over-Year Change
Research and development spending
3Y CAGR
-21.6%/yr
Annual compound
5Y CAGR
+2.1%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.60M | -52.8% |
| 2024 | $41.51M | -22.5% |
| 2023 | $53.54M | +31.6% |
| 2022 | $40.69M | +51.2% |
| 2021 | $26.91M | +52.6% |
| 2020 | $17.63M | +55.1% |
| 2019 | $11.37M | - |